Psyence Biomedical Warrant
PBMWW
19 hedge funds and large institutions have $96.6K invested in Psyence Biomedical Warrant in 2026 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
4% less capital invested
Capital invested by funds: $101K → $96.6K (-$4.45K)
1.59% less ownership
Funds ownership: 42.06% → 40.47% (-1.6%)
10% less funds holding
Funds holding: 21 → 19 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$280 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.44K |
| 3 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$625 |
PBMWW Hedge Fund Activity: Q1 2026 in Review
19 of the 8,186 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical Warrant (PBMWW) for Q1 2026, worth a combined $96.6K — down 4.4% from $101K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of PBMWW and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Virtu Financial, adding an estimated $280. The largest seller was Osaic Holdings, exiting entirely with an estimated $2K sold.
- 19 institutional investors held Psyence Biomedical Warrant (PBMWW) as of Q1 2026, down from 21 in Q4 2025.
- Funds reported $96.6K of Psyence Biomedical Warrant stock for Q1 2026, down 4.4% quarter-over-quarter.
- 1 fund opened new Psyence Biomedical Warrant positions in Q1 2026 and 3 closed out, a net change of -2 holders.
- The largest Psyence Biomedical Warrant buyer in Q1 2026 was Virtu Financial, an estimated $280 added.
- The largest Psyence Biomedical Warrant seller in Q1 2026 was Osaic Holdings, an estimated $2K sold.
Based on aggregated 13F filings for Q1 2026.